Wells Fargo’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Sell
24,600
-37,952
-61% -$2.15M ﹤0.01% 3404
2025
Q4
$2.6M Buy
62,552
+26,297
+73% +$1.09M ﹤0.01% 3231
2025
Q3
$1.46M Buy
36,255
+1,600
+5% +$46.5K ﹤0.01% 3545
2025
Q2
$901K Buy
34,655
+508
+1% +$12.2K ﹤0.01% 3758
2025
Q1
$836K Buy
34,147
+5,913
+21% +$166K ﹤0.01% 3767
2024
Q4
$810K Buy
28,234
+8,803
+45% +$301K ﹤0.01% 3858
2024
Q3
$733K Buy
19,431
+8,885
+84% +$311K ﹤0.01% 3748
2024
Q2
$333K Buy
10,546
+923
+10% +$32K ﹤0.01% 4174
2024
Q1
$422K Buy
+9,623
New +$393K ﹤0.01% 4001

Other funds holding CGON